 |
| Editorial |  Top |
|
 |
|
End of the interlude? p1191
doi:10.1038/nbt1004-1191
Full text | PDF
(52K)
|
|
| News | Top |
|
|
|
Profile: Fritjof Capra p1201
Laura DeFrancesco
doi:10.1038/nbt1004-1201
Abstract | Full text | PDF
(102K)
|
|
| Opinion and Comment | Top |
|
|
|
| Commentary |
|
|
|
A partnership between biology and engineering pp1211 - 1214
Roger Brent
doi:10.1038/nbt1004-1211
Full text | PDF
(104K)
|
|
|
|
The impact of systems approaches on biological problems in drug discovery pp1215 - 1217
Leroy Hood
& Roger M Perlmutter
doi:10.1038/nbt1004-1215
Full text | PDF
(182K)
|
|
|
|
Two-dimensional annotation of genomes pp1218 - 1219
Bernhard Palsson
doi:10.1038/nbt1004-1218
Full text | PDF
(111K)
|
|
| Feature | Top |
|
|
|
Can complexity be commercialized? pp1223 - 1229
George S Mack
doi:10.1038/nbt1004-1223
Abstract | Full text | PDF
(620K)
|
|
| Historical Perspective | Top |
|
|
|
The evolution of molecular biology into systems biology pp1249 - 1252
Hans V Westerhoff
& Bernhard O Palsson
Published online: 06 October 2004 | doi:10.1038/nbt1020
Abstract | Full text | PDF
(110K)
|
|
| Research | Top |
|
|
|
| Perspective |
|
|
|
Systems biology in drug discovery pp1253 - 1259
Eugene C Butcher, Ellen L Berg
& Eric J Kunkel
Published online: 06 October 2004 | doi:10.1038/nbt1017
Abstract | Full text | PDF
(438K)
|
|
 |
|
| Reviews |
|
|
|
Exploiting biological complexity for strain improvement through systems biology pp1261 - 1267
Gregory Stephanopoulos, Hal Alper
& Joel Moxley
Published online: 06 October 2004 | doi:10.1038/nbt1016
Abstract | Full text | PDF
(511K)
|
|
|
|
The challenges of modeling mammalian biocomplexity pp1268 - 1274
Jeremy K Nicholson, Elaine Holmes, John C Lindon
& Ian D Wilson
Published online: 06 October 2004 | doi:10.1038/nbt1015
Abstract | Full text | PDF
(464K)
|
|
|
Top |
|
|
